Roboearth – Lifestyle
Author:
CVRx, Inc.
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
May 4, 2026
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
April 27, 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
April 20, 2026
CVRx Reports Preliminary First Quarter 2026 Financial Results
April 13, 2026